<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02787707</url>
  </required_header>
  <id_info>
    <org_study_id>MashhadUMS</org_study_id>
    <nct_id>NCT02787707</nct_id>
  </id_info>
  <brief_title>Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting</brief_title>
  <official_title>ŸçEffect of Iranian Traditional Medicine Remedy Compared With Placebo on Chemotherapy Induced Nausea and Vomiting in Breast Cancer; a Double-blind Randomized Controlled Cross-over Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mashhad University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mashhad University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this research is the role of the Persumac(an Iranian traditional
      remedy) on refractory Chemotherapy Induced Nausea and Vomiting (CINV) in breast cancer
      patients. Investigators assess effect of Persumac on the number/severity of nausea/ vomiting
      in acute and delayed phase.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was a double-blind, placebo controlled, Cross-over clinical trial of Iranian
      traditional remedy (Persumac) on chemotherapy induced nausea and vomiting in breast cancer
      patients. From October 2015 to May 2016, sample selection continued to be until the full
      sample size.

      Executive steps of study:

        1. Among patients referred for breast cancer, to the oncology clinic in Imam Reza hospital
           in Mashhad University of Medical Sciences, an oncology referral center in the North East
           of Iran; patients included in study who had at least one chemotherapy session and remain
           at least three sessions of Their chemotherapy cycle and had inclusion criteria.

        2. The initial assessment of patients (Run- in): Concurrent with the visit of patient for
           chemotherapy (the first session of her/his chemotherapy in this study); during
           interview, study questionnaire was delivered to patient. It took a full explanation of
           how to complete it and return the next session.

        3. In the second session of chemotherapy (in study); after eligibility qualification and
           obtaining consent form, patients randomly allocated into intervention and control
           groups, In accordance with the study protocol, interventions take place. Questionnaire
           was delivered to the patient again.

        4. (Wash out): Sixth day after the second session of chemotherapy until a day before the
           third session of chemotherapy determined as Wash out period.

        5. In the third session of chemotherapy-in study, after obtaining the previous
           questionnaire, patient received cross over interventions. Questionnaire delivered to the
           patient again.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency and Severity of nausea and vomiting in acute phase</measure>
    <time_frame>first 24 hour after chemotherapy</time_frame>
    <description>number and severity of nausea and vomiting, acquired from questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency and Severity of nausea and vomiting in acute phase</measure>
    <time_frame>Day 2-5 of chemotherapy</time_frame>
    <description>number and severity of nausea and vomiting, acquired from questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Nausea</condition>
  <condition>Vomiting</condition>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2.7 grams Persumac powder (Iranian traditional medicine remedy composed from sumac and Bunium Persicum) every 8 hour from 24 hour before to fifth day after chemotherapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2.7 grams Lactose every 8 hour from 24 hour before to fifth day after chemotherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Persumac</intervention_name>
    <description>2.7 grams Persumac powder (Iranian traditional medicine remedy composed from sumac and Bunium Persicum) every 8 hour</description>
    <arm_group_label>intervention</arm_group_label>
    <other_name>Sumac and black Zirah</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lactose</intervention_name>
    <description>2.7 grams Lactose every 8 hour</description>
    <arm_group_label>control</arm_group_label>
    <other_name>Lactose powder</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Clinical diagnosis of breast cancer,

          -  Clinical diagnosis of chemotherapy induced nausea and vomiting resistant to
             conventional therapy.

        Exclusion Criteria:

          -  Clinical diagnosis of hypersensitivity to Sumac or Bunium Persicum,

          -  Clinical diagnosis of digestion disorders,

          -  Clinical diagnosis of non chemotherapy induced nausea and vomiting,

          -  Milk allergy,

          -  Clinical diagnosis of bleeding diathesis,

          -  Clinical diagnosis of non-breast cancer.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Nazari, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>School of Persian and Complementary medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Oncology, Imam Reza Hospital, Mashhad University of Medical Sciences</name>
      <address>
        <city>Mashhad</city>
        <state>Khorasan Razavi</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2016</study_first_submitted>
  <study_first_submitted_qc>May 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2016</study_first_posted>
  <last_update_submitted>June 2, 2016</last_update_submitted>
  <last_update_submitted_qc>June 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mashhad University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Sadegh Shokri</investigator_full_name>
    <investigator_title>Ph.D candidate of Persian medicine</investigator_title>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <keyword>Traditional medicine</keyword>
  <keyword>Chemotherapy Induced Nausea and Vomiting</keyword>
  <keyword>Bunium Persicum</keyword>
  <keyword>Rhus Coriaria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Publication</ipd_description>
  </patient_data>
  <pending_results>
    <submitted>August 31, 2016</submitted>
    <returned>October 21, 2016</returned>
    <submitted>November 1, 2016</submitted>
    <returned>December 28, 2016</returned>
    <submitted>January 2, 2017</submitted>
    <returned>February 20, 2017</returned>
    <submitted>March 29, 2017</submitted>
    <returned>June 14, 2017</returned>
    <submitted>July 3, 2017</submitted>
    <returned>February 1, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

